Phibro Animal Health Corporation

NASDAQ:PAHC

Drug Manufacturers - Specialty & Generic

Healthcare
$35.57 +1.23%

+$0.38 today

Market cap
$1.44B
Beta
0.46
P/E (TTM)
13.3
EPS (TTM)
$2.35
Dividend yield
1.54%
52W Low $23.57High $60.08

Volume 0.11M

Average 0.37M

PAHC Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Phibro Animal Health CorporationNASDAQ: PAHC

Total Equity · Q3 FY2026 · quarter ended Mar 2026

Total equity rises 36.0% from a year ago

Total equity stood at $361.83M at the end of Q3 FY2026, up 36.0% from a year earlier and up 8.9% from the prior quarter. Over 3 fiscal years it compounded at +2.9% a year.

Context

  • Total equity amounted to 25.0% of total assets at the end of Q3 FY2026, up 4.8 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps rising in the next quarterly balance sheet after a +36.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$361.83M+8.9% QoQ
Last fiscal yearJun 2025
$285.68M+11.3% YoY
Year agoMar 2025
$265.99M+36.0% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.0%——
1 year+11.3%——
3-year CAGR+2.9%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
285.68M USD
Year-over-year change
+11.3%
4-year CAGR
+4.6%

Total Equity vs competitors

How PAHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +36.0% is the highest of 6, against a peer median of -13.0%.
  • Total equity amounts to 25.0% of total assets for PAHC, versus a peer median of 49.7%.
PAHC Competitors
Total Equity for PAHC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MRKMerck & Co., Inc.Jun 2026$41.98B USD-14.4%+4.6%32.3%
ELANElanco Animal Health IncorporatedSep 2026$6.63B USD-1.8%-3.5%49.7%
ZTSZoetis Inc.Jun 2026$3.15B USD-36.7%-8.9%20.9%
NEOGNeogen CorporationAug 2026$2.09B USD-1.5%-12.6%63.2%
PAHCPhibro Animal Health CorporationMar 2026$361.83M USD+36.0%+2.9%25.0%
ZYBTZhengye Biotechnology Holding LimitedDec 2025CN¥306.72M CNY-13.0%-4.9%70.3%
Peer median (excluding PAHC) —-13.0%-4.9%49.7%

Competitors are the stored peer set for PAHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Cash & Equivalents50.21M74.25M41.28M70.61M68.04M
Short-term Investments43M17M40M44M9M
Net Receivables146.85M166.54M163.48M169.45M227.98M
Inventory216.31M259.16M277.57M265.91M444.43M
Other Current Assets42.53M49.29M63.39M51.02M61.16M
Total Current Assets498.91M566.23M585.72M601M810.61M
Property, Plant & Equipment (Net)187.67M203.17M231.33M240.9M396.03M
Goodwill52.68M53.23M53.27M54.56M59.65M
Intangible Assets62.28M63.86M54.99M45.03M36.47M
Long-term Investments10.11M10.35M11.09M11.49M11.69M
Tax Assets9.86M5.85M8.71M19.37M25.55M
Other Non-current Assets19.82M29.02M26.28M9.83M20.91M
Total Non-current Assets342.42M365.47M385.67M381.19M550.29M
Total Assets841.33M931.7M971.4M982.18M1.36B
Account Payables68.36M95.6M73.85M85.57M138.2M
Short-term Debt9.38M15M22.3M29.8M16.25M
Tax Payables6.11M7.21M8.66M2.93M8.4M
Deferred Revenue00000
Other Current Liabilities56.21M53.18M48.22M55.15M83M
Total Current Liabilities164.12M190.83M176M204.15M293.47M
Long-term Debt382.71M417.93M452.54M458.29M702.44M
Deferred Tax Liabilities6.65M9.26M12.15M14.22M19.47M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities21.32M19.73M19.12M18.97M26.1M
Total Non-current Liabilities438.68M478.43M512.89M521.4M781.75M
Total Liabilities602.8M669.26M688.89M725.54M1.08B
Common Stock4K4K4K4K4K
Retained Earnings218.02M247.75M260.91M243.89M272.7M
Accumulated OCI(115.29M)(121.11M)(114.21M)(123.53M)(124.02M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity238.53M262.44M282.51M256.64M285.68M
Total Debt426.71M470.48M509.97M525.46M761.55M
Net Debt376.49M396.24M468.69M454.85M693.51M

Phibro Animal Health Corporation

NASDAQ:PAHC

Intrinsic Alpha fair value

Locked

Current Price

$35.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.